investors.vir.bioVir Biotechnology, Inc. - Investor
investors.vir.bio Profile
Investors.vir.bio is a subdomain of Vir.bio, which was created on 2016-03-11,making it 8 years ago.
Discover investors.vir.bio website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
investors.vir.bio Information
| HomePage size: 118.556 KB |
| Page Load Time: 0.128608 Seconds |
| Website IP Address: 162.159.130.11 |
investors.vir.bio Similar Website
| Synopsys, Inc. | Investor Relations & Investor Resources |
| IMBA - Institute of Molecular Biotechnology |
| Block, Inc. (SQ) Investor Relations - Investor Relations |
| KUBiC - Exploring Biotechnology Excellence | Kathmandu University |
| Institute for Bioscience and Biotechnology Research |
| Seed Biotechnology Center |
| National Center for Biotechnology Information |
| Puma Biotechnology, Inc. - Investor Relations |
| Amgen | A Worldwide Pioneer in Biotechnology |
| Vir tú Spa |
| ICBB2024 | ICBB2024 | 2024 the 14th International Conference on Biotechnology and Bioengineering (14 |
| Evolutionary Genomics and Bioinformatics Group – Dept. of Genetics & Inst. of Biotechnology, Univer |
| New Jersey Motor Vehicle Commission - VIR Printing |
| Biotechnology Conferences | Top Biotechnology Conferences | Biotechnology Events | Industrial Biotec |
| Welcome - Aga Khan Foundation USA: Virtual Voyage: Going the Distance : Aga Khan Foundation USA: Vir |
investors.vir.bio PopUrls
| Vir Biotechnology, Inc. - Investor Relations https://investors.vir.bio/overview/default.aspx |
| Vir Biotechnology, Inc. - News https://investors.vir.bio/news/default.aspx |
| Governance Documents https://investors.vir.bio/governance/governance-documents/default.aspx |
| united states securities and exchange commission https://investors.vir.bio/files/doc_financials/2024/q1/10-Q.pdf |
| Site Map https://investors.vir.bio/site-map/default.aspx |
| Vir Biotechnology, Inc. - Stock Info https://investors.vir.bio/stock-info/default.aspx |
| Vir Biotechnology, Inc. - Financials - Quarterly Reports https://investors.vir.bio/financials/quarterly-results/default.aspx |
| 10-K (File https://investors.vir.bio/files/doc_financials/2023/q4/93f1e439-fbb6-4d85-9b06-5e52090d50a9.pdf |
| Financials - SEC Filings https://investors.vir.bio/financials/sec-filings/default.aspx |
| Vir Biotechnology, Inc. - Vir Biotechnology Provides Corporate Update ... https://investors.vir.bio/news/news-details/2023/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-Second-Quarter-2023-Financial-Results-08-03-2 |
| Vir Biotechnology, Inc. - Vir Biotechnology Completes Enrollment of ... https://investors.vir.bio/news/news-details/2024/Vir-Biotechnology-Completes-Enrollment-of-Phase-2-Chronic-Hepatitis-Delta-SOLSTICE-Trial-Ahead-of-Sch |
| Vir Biotechnology Provides Corporate Update and Reports First Quarter ... https://investors.vir.bio/news/news-details/2023/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-First-Quarter-2023-Financial-Results-05-04-20 |
| Vir Biotechnology, Inc. - Vir Biotechnology Provides Corporate Update ... https://investors.vir.bio/news/news-details/2022/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-Third-Quarter-2022-Financial-Results-11-03-20 |
| Vir Biotechnology, Inc. - Vir Biotechnology Provides Corporate Update ... https://investors.vir.bio/news/news-details/2022/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-R |
| Vir Biotechnology Provides Corporate Update and Reports First Quarter ... https://investors.vir.bio/news/news-details/2022/Vir-Biotechnology-Provides-Corporate-Update-and-Reports-First-Quarter-2022-Financial-Results-05-05-20 |
investors.vir.bio Httpheader
| Date: Wed, 15 May 2024 09:25:55 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| CF-Ray: 8842155feade52b9-LAX |
| CF-Cache-Status: REVALIDATED |
| Cache-Control: public, max-age=10, stale-if-error=86400, stale-while-revalidate=86400 |
| Strict-Transport-Security: max-age=31536000; includeSubDomains |
| Vary: Accept-Encoding |
| X-Content-Type-Options: nosniff |
| X-Frame-Options: SAMEORIGIN |
| X-XSS-Protection: 1; mode=block |
| Server: |
investors.vir.bio Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-type"/ |
| content="RevealTrans(Duration=0,Transition=0)" http-equiv="Page-Enter"/ |
| content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
| content="default-src 'self' https: http: 'unsafe-inline' 'unsafe-eval' *.q4inc.com; script-src 'self' *.bootstrapcdn.com unpkg.com *.jsdelivr.net *.unpkg.com *.datatables.net *.cloudfront.net *.pusherapp.com *.newrelic.com *.nr-data.net *.bugherd.com *.q4cdn.com *.q4web.com *.amazonaws.com *.highcharts.com *.googletagmanager.com *.googleadservices.com *.google-analytics.com *.google.com *.gstatic.com *.q4app.com *.pendo.io 'unsafe-inline' 'unsafe-eval' *.q4inc.com" |
investors.vir.bio Html To Plain Text
Relations Overview News Events & Presentations Stock Info Stock Quote Analyst Coverage Financials Quarterly Reports SEC Filings Governance Governance Documents Committee Composition Confidential and Anonymous Financial Concern Hotline Code of Business Conduct and Ethics Hotline Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Powering the Immune System to Transform Lives Investor Relations Vir is leveraging immunologic breakthroughs to address unmet patient needs in infectious disease and beyond. View our pipelineOverview News Events & Presentations Stock Info Stock Quote Analyst Coverage Financials Quarterly Reports SEC Filings Governance Governance Documents Committee Composition Confidential and Anonymous Financial Concern Hotline Code of Business Conduct and Ethics Hotline Resources Investor FAQs Information Request Form Investor Email Alerts Investor Contacts Why Invest 9Phase 2 Catalysts Expected 2Planned Growth Beyond Hepatitis 6Financial Strength 20 + Peer-Reviewed Scientific Journals with Vir PublicationsLatest News View All Latest Events & Presentation View All Events & Presentations Latest Quarterly Reports View All Financial Reports Quick Links Vir Corporate Site Our Science Our Pipeline Our Leadership Our Careers IR Contact Vir Biotechnology, Inc. 1800 Owens St., Suite 900 San Francisco, CA 94158 contact us by phone 415-906-4324 [email protected] Follow us opens in a new window opens in a new window Investor Email Alerts To opt in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time. At Vir Biotechnology, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. By providing your email address below, you are providing consent to Vir Biotechnology to send you the requested Investor Email Alert updates. * Required Email Address * Investor Alert Options Investor Alert Options * News Events & Presentations Quarterly Results Annual Reports SEC Filings UnsubscribeEmail Alert Sign Up Confirmation REQUEST A MEETING WITH MANAGEMENTPrivacy Policy Cookie Policy Terms of Use Opt-Out Guide Site Map © Vir Biotechnology, Inc TM - All rights reserved Powered By Q4 Inc. 5.122.0.3 (opens in...
investors.vir.bio Whois
Domain Name: vir.bio Registry Domain ID: 586ee902f40448c0a1b61a3596ff6b10-DONUTS Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://www.networksolutions.com Updated Date: 2022-01-15T10:53:00Z Creation Date: 2016-03-11T18:19:30Z Registry Expiry Date: 2027-03-11T18:19:30Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Registrant State/Province: FL Registrant Country: US Name Server: ns11.worldnic.com Name Server: ns12.worldnic.com DNSSEC: unsigned >>> Last update of WHOIS database: 2024-05-18T02:33:10Z <<<